Cargando…
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses
BACKGROUND: Shorter duration of symptoms before remdesivir has been associated with better outcomes. Our goal was to evaluate variables associated with the need of ICU admission in a cohort of hospitalized patients for COVID-19 under remdesivir including the period from symptoms onset to remdesivir....
Autores principales: | Alonso-Navarro, Rodrigo, Ramírez, Margarita, Masiá, Mar, Paredes, Roger, Montejano, Rocío, Povar-Echeverria, Marina, Carratalà, Jordi, Salavert, Miguel, Bernal, Enrique, Dueñas, Carlos, Flores, Juan, Fanjul, Francisco, Gutiérrez, Isabel, Rico, Verónica, Mateu, Lourdes, Cadiñanos, Julen, Berenguer, Juan, Soriano, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157565/ https://www.ncbi.nlm.nih.gov/pubmed/37142994 http://dx.doi.org/10.1186/s12879-023-08222-y |
Ejemplares similares
-
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain
por: Soriano, Alejandro, et al.
Publicado: (2021) -
Real-life use of remdesivir in hospitalized patients with COVID-19
por: Garcia-Vidal, Carolina, et al.
Publicado: (2021) -
REMDESIVIR-ASSOCIATED ASYMPTOMATIC BRADYCARDIA IN AN ICU PATIENT ON DEXAMETHASONE FOR COVID-19
por: HAIDER, MOBEEN, et al.
Publicado: (2022) -
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
por: Moreno, Santiago, et al.
Publicado: (2022) -
Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients
por: Micán, Rafael, et al.
Publicado: (2022)